Resumo
Background: Melanoma is the most frequent cancer in the canine oral cavity. It shows an aggressive behavior, characterized by rapid and invasive growth and high metastatic potential. Metastasis is seen in more than 80% of dogs at time ofdeath. Adjuvant therapy should be recommended because of potential recurrence and metastasis. Oral melanoma has a poorprognosis even when adjuvant treatments are used. There are some treatment options, but the high death rate due to thedisease is still a challenge. The aim of this study was to assess the overall survival of dogs diagnosed with oral melanomaand treated with adjuvant chemotherapy and immunotherapy.Materials, Methods & Results: A retrospective analysis was carried out in 20 dogs with oral melanocytic or amelanocyticmelanomas. Cases were staged according to a modified World Health Organization clinical staging system for canine oralmalignant melanoma. Tumor size (T1: 4 cm), regional metastasis (N0: no metastasis; N1:metastasis) and presence of distant metastasis (M0: no metastasis; M1: metastasis) are evaluated. Then, cases were dividedinto 4 stages: I (T1 N0 M0), II (T2 N0 M0), III (T3 N0-1 M0, Tx N1 M0) and IV (Tx Nx M1). Diagnoses were confirmedwith histopathological exam and immunohistochemistry (IHC) when necessary. In poorly differentiated neoplasms, IHC wasperformed at the request of the submitting veterinarian using specific markers PNL-2 and Melan-A. Animals were dividedinto 2 groups: dogs submitted to surgery alone were included in group 1 (G1); dogs submitted...
Assuntos
Animais , Cães , Cães , Imunoterapia/veterinária , Melanoma/veterinária , Neoplasias Bucais/veterinária , Quimioterapia Adjuvante/veterinária , Imuno-Histoquímica/veterinária , Metástase NeoplásicaResumo
Background: Melanoma is the most frequent cancer in the canine oral cavity. It shows an aggressive behavior, characterized by rapid and invasive growth and high metastatic potential. Metastasis is seen in more than 80% of dogs at time ofdeath. Adjuvant therapy should be recommended because of potential recurrence and metastasis. Oral melanoma has a poorprognosis even when adjuvant treatments are used. There are some treatment options, but the high death rate due to thedisease is still a challenge. The aim of this study was to assess the overall survival of dogs diagnosed with oral melanomaand treated with adjuvant chemotherapy and immunotherapy.Materials, Methods & Results: A retrospective analysis was carried out in 20 dogs with oral melanocytic or amelanocyticmelanomas. Cases were staged according to a modified World Health Organization clinical staging system for canine oralmalignant melanoma. Tumor size (T1: < 2 cm; T2: 2 - 4 cm; T3: > 4 cm), regional metastasis (N0: no metastasis; N1:metastasis) and presence of distant metastasis (M0: no metastasis; M1: metastasis) are evaluated. Then, cases were dividedinto 4 stages: I (T1 N0 M0), II (T2 N0 M0), III (T3 N0-1 M0, Tx N1 M0) and IV (Tx Nx M1). Diagnoses were confirmedwith histopathological exam and immunohistochemistry (IHC) when necessary. In poorly differentiated neoplasms, IHC wasperformed at the request of the submitting veterinarian using specific markers PNL-2 and Melan-A. Animals were dividedinto 2 groups: dogs submitted to surgery alone were included in group 1 (G1); dogs submitted...(AU)
Assuntos
Animais , Cães , Cães , Melanoma/veterinária , Quimioterapia Adjuvante/veterinária , Imunoterapia/veterinária , Neoplasias Bucais/veterinária , Metástase Neoplásica , Imuno-Histoquímica/veterináriaResumo
Extramedullary plasmacytomas (EPs) are responsible for 2.5% of neoplasms in dogs. They are solitary, smooth, elevated, pink or red nodules, of 1 to 2cm in diameter. Cutaneous and oral extramedullary plasmacytomas in dogs are usually benign tumors, treated with local therapies. Prognosis is generally good. Recurrence and metastatic rates are low. Electrochemotherapy is a local treatment that combines chemotherapy and electroporation and shows objective responses of 70% to 94% with few local and systemic side effects. This scientific communication has the objective to report treatment of three canine patients with oral extramedullary plasmacytoma. Nodules were located on the tongue and patients were submitted to one or two electrochemotherapy sessions, which preserved the tongue without mutilation and cured the patients.
Plasmocitomas extramedulares (PE) são responsáveis por 2,5% das neoplasias em cães. São nódulos solitários, lisos, elevados, rosados ou avermelhados, de 1 a 2cm de diâmetro. O plasmocitoma extramedular cutâneo e oral em cães é um tumor tipicamente benigno tratado com terapias locais. O prognóstico geralmente é bom. As taxas de recorrência e metástase são baixas. A eletroquimioterapia é um tratamento local que combina quimioterapia e eletroporação e mostra respostas objetivas entre 70 a 94% com poucos efeitos colaterais locais e sistêmicos. Esta comunicação científica teve como objetivo relatar o tratamento de três pacientes caninos com plasmocitoma extramedular oral com lesões localizadas na língua submetidos a uma ou duas sessões de eletroquimioterapia, o que permitiu a manutenção da língua sem mutilação e proporcionou a cura dos pacientes.
Assuntos
Animais , Cães , Cães , Eletroquimioterapia , Língua , PlasmocitomaResumo
Extramedullary plasmacytomas (EPs) are responsible for 2.5% of neoplasms in dogs. They are solitary, smooth, elevated, pink or red nodules, of 1 to 2cm in diameter. Cutaneous and oral extramedullary plasmacytomas in dogs are usually benign tumors, treated with local therapies. Prognosis is generally good. Recurrence and metastatic rates are low. Electrochemotherapy is a local treatment that combines chemotherapy and electroporation and shows objective responses of 70% to 94% with few local and systemic side effects. This scientific communication has the objective to report treatment of three canine patients with oral extramedullary plasmacytoma. Nodules were located on the tongue and patients were submitted to one or two electrochemotherapy sessions, which preserved the tongue without mutilation and cured the patients.(AU)
Plasmocitomas extramedulares (PE) são responsáveis por 2,5% das neoplasias em cães. São nódulos solitários, lisos, elevados, rosados ou avermelhados, de 1 a 2cm de diâmetro. O plasmocitoma extramedular cutâneo e oral em cães é um tumor tipicamente benigno tratado com terapias locais. O prognóstico geralmente é bom. As taxas de recorrência e metástase são baixas. A eletroquimioterapia é um tratamento local que combina quimioterapia e eletroporação e mostra respostas objetivas entre 70 a 94% com poucos efeitos colaterais locais e sistêmicos. Esta comunicação científica teve como objetivo relatar o tratamento de três pacientes caninos com plasmocitoma extramedular oral com lesões localizadas na língua submetidos a uma ou duas sessões de eletroquimioterapia, o que permitiu a manutenção da língua sem mutilação e proporcionou a cura dos pacientes.(AU)